Insider Transactions in Q3 2021 at Bio Rad Laboratories, Inc. (BIO)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2021
|
Andrew J. Last EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,000
-26.81%
|
$1,626,000
$813.17 P/Share
|
|
Sep 01
2021
|
Andrew J. Last EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+37.87%
|
$598,000
$299.24 P/Share
|
|
Aug 26
2021
|
Annette Tumolo Executive Vice President |
SELL
Open market or private sale
|
Direct |
600
-16.22%
|
$475,200
$792.58 P/Share
|
|
Aug 09
2021
|
Michael Crowley EVP, GBL Commercial Operations |
SELL
Open market or private sale
|
Direct |
3,000
-24.51%
|
$2,265,000
$755.26 P/Share
|
|
Aug 09
2021
|
Michael Crowley EVP, GBL Commercial Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+31.03%
|
$417,000
$139.56 P/Share
|
|
Aug 04
2021
|
Ilan Daskal EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,300
-67.18%
|
$1,729,600
$752.05 P/Share
|
|
Aug 04
2021
|
Ilan Daskal EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+37.77%
|
$432,600
$309.84 P/Share
|
|
Aug 04
2021
|
Timothy S Ernst EVP, General Counsel & Sec |
SELL
Open market or private sale
|
Direct |
327
-26.24%
|
$248,520
$760.26 P/Share
|